Ramipril and Trichorrhexis - a phase IV clinical study of FDA data

Summary:

Trichorrhexis is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Ocrevus, and have Macular oedema.

The phase IV clinical study analyzes which people have Trichorrhexis when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Trichorrhexis?

Trichorrhexis (a condition in which the hairs break) is found to be associated with 262 drugs and 384 conditions by eHealthMe. Check the latest studies of Trichorrhexis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 23 people (0.02%) have Trichorrhexis.

Among these 23 people:

How long have people been on Ramipril when they have Trichorrhexis? *

What is the gender of people who have Trichorrhexis when taking Ramipril? *

female: 100 %
male: 0.0 %

What is the age of people who have Trichorrhexis when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Trichorrhexis? *

Hair Loss: 22 people, 95.65%
Rashes (redness): 21 people, 91.30%
Fatigue (feeling of tiredness): 21 people, 91.30%
Weakness: 20 people, 86.96%
Visual Impairment: 20 people, 86.96%
Hypoaesthesia (reduced sense of touch or sensation): 20 people, 86.96%
Memory Loss: 20 people, 86.96%
Micturition Urgency (urgency to pass the urine): 20 people, 86.96%
Mobility Decreased (ability to move is reduced): 20 people, 86.96%
Nausea (feeling of having an urge to vomit): 20 people, 86.96%

What are the existing conditions these people have? *

Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 19 people, 82.61%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 19 people, 82.61%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.70%
Nail Disorder (disease of nail): 1 person, 4.35%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 1 person, 4.35%
Hair Loss: 1 person, 4.35%
Hair Disorder: 1 person, 4.35%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Trichorrhexis?

- Check whether Trichorrhexis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Trichorrhexis treatments and more:

Trichorrhexis (2,969 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Trichorrhexis:

Trichorrhexis (262 drugs)

Browse all the conditions that are associated with Trichorrhexis:

Trichorrhexis (384 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.